logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
10/04/2026
Lee Changyong: One should not overinterpret the trend of the Korean won against the backdrop of overall US dollar fluctuations.
Latest
3 m ago
The Governor of the Bank of Korea warned that the conflict in the Middle East will worsen inflation.
3 m ago
Hanwang Technology launches a new 7.1-inch e-reader product.
4 m ago
Ali claims HappyHorse: Currently still in internal testing, API will be open soon.
5 m ago
Ceasefire agreement boost Asian stock markets, potentially bringing the best single-week performance since 2022.
5 m ago
According to Mei AI News, Huayuan Securities released a research report on April 10, giving Wumei Biology (603983.SH) a "buy" rating. The main reasons for the rating include: 1) The revenue of eye care and skincare products is growing well; 2) The company's net profit margin has slightly decreased, while the sales expense ratio continues to rise. (Daily Economic News)
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.